Evaluating SVEAT score performance is becoming essential for emergency departments lacking catheterization labs. Chest pain remains a high-volume presentation that often triggers unnecessary transfers to tertiary centers. Consequently, risk stratification tools are necessary to identify low-risk patients safely. A recent study compared the SVEAT and HEART scores to determine which better predicts 30-day major adverse cardiac events (MACE).

Analyzing SVEAT Score Performance and Accuracy

The prospective study included 230 adult patients with non-traumatic chest pain. These patients were referred from secondary-level EDs without percutaneous coronary intervention (PCI) capability. Specifically, the SVEAT score demonstrated a higher area under the ROC curve at 0.969 compared to 0.948 for the HEART score. Furthermore, the SVEAT score showed significantly higher specificity at 98.1%. Although the HEART score had a higher sensitivity of 88.9%, SVEAT's positive predictive value was superior at 95.1%. Therefore, the SVEAT score offers a more precise tool for avoiding unnecessary coronary referrals.

Clinical Implications for Non-PCI Centers

Using highly specific scores helps clinicians make more individualized referral decisions. In India, where many secondary care centers lack immediate cath lab access, this accuracy is crucial. Moreover, the SVEAT score includes symptoms, vascular history, ECG, age, and troponin levels. This structured framework, when combined with clinical judgment, effectively identifies patients who do not require urgent transfer. Consequently, this reduces the burden on tertiary care facilities and optimizes resource allocation.

Frequently Asked Questions

What are the components of the SVEAT score?

The SVEAT score includes five key clinical variables: Symptoms, history of Vascular disease, Electrocardiography, Age, and Troponin levels. These factors help clinicians stratify the risk of major adverse cardiac events.

How does SVEAT differ from the HEART score?

While both scores use similar variables, SVEAT places different weights on symptoms and vascular history. In recent studies, SVEAT has shown higher specificity and overall diagnostic accuracy than the HEART score.

Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a substitute for professional healthcare consultation. Refer to the latest local and national guidelines for clinical practice.

References

Zaman S et al. SVEAT vs. HEART scores for avoiding unnecessary coronary referrals in ED chest pain patients without cath labs. Heart Lung. 2026 May 12. doi: undefined. PMID: 42119270.

Roongsritong C et al. SVEAT score: a new clinical prediction score for 30-day major adverse cardiovascular events in patients with chest pain. Am J Emerg Med. 2020 Oct;38(10):2153-2158.

Antwi-Amoabeng D et al. SVEAT score for early risk stratification of acute chest pain: a multicenter study. Heart & Lung. 2024. doi:10.1016/j.hrtlng.2024.01.002.